Osaic Holdings’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52.4K Buy
2,917
+2
+0.1% +$40 ﹤0.01% 5176
2025
Q4
$68.3K Sell
2,915
-11,975
-80% -$260K ﹤0.01% 5019
2025
Q3
$287K Buy
14,890
+11,195
+303% +$201K ﹤0.01% 3913
2025
Q2
$50.3K Buy
3,695
+3,070
+491% +$29.5K ﹤0.01% 5051
2025
Q1
$6.91K Sell
625
-1,044
-63% -$11.1K ﹤0.01% 5999
2024
Q4
$17.8K Buy
1,669
+1,057
+173% +$12.7K ﹤0.01% 5423
2024
Q3
$7.77K Buy
612
+202
+49% +$3K ﹤0.01% 5970
2024
Q2
$6.88K Sell
410
-253
-38% -$3.6K ﹤0.01% 6012
2024
Q1
$9.95K Hold
663
﹤0.01% 5743
2023
Q4
$9.95K Sell
663
-543
-45% -$7.05K ﹤0.01% 5831
2023
Q3
$16.9K Buy
1,206
+586
+95% +$9.41K ﹤0.01% 5635
2023
Q2
$6.42K Hold
620
﹤0.01% 6193
2023
Q1
$5.73K Sell
620
-20
-3% -$184 ﹤0.01% 6262
2022
Q4
$5K Buy
640
+20
+3% +$189 ﹤0.01% 6313
2022
Q3
$5K Hold
620
﹤0.01% 6396
2022
Q2
$5K Buy
620
+120
+24% +$824 ﹤0.01% 6506
2022
Q1
$4K Hold
500
﹤0.01% 6642
2021
Q4
$5K Buy
+500
New +$7.05K ﹤0.01% 6663

Other funds holding URGN